StrokeDx, a pioneering force in next-generation stroke technology, has proudly announced the completion of its Series Seed Prime funding round, securing $5 million. Spearheaded by DigiTx Partners and joined by Freeflow Ventures and existing investors with notable accomplishments in neuroradiology, stroke, and medical devices, this round was oversubscribed.

Managing Director of DigiTx Partners, will be joining the board. With this latest funding, StrokeDx has now raised close to $10 million, which includes a grant from the National Institutes of Health (NIH) R01. This fresh influx of capital will be utilized to further validate StrokeDx’s innovative technology clinically and expand its commercial endeavors.

StrokeDx specializes in the development of advanced technologies and software aimed at enabling portable, non-invasive, and non-radiating cerebrovascular monitoring.

The company’s approach, spearheaded by Dr. Shane Shahrestani, MD, PhD, at the California Institute of Technology (Caltech), offers a unique and highly precise method for stroke surveillance using cutting-edge technology.

The societal impact of StrokeDx’s technology is profound, offering a scalable solution to enhance stroke outcomes for millions of individuals at risk. By leveraging portable devices, StrokeDx addresses crucial issues in healthcare accessibility and equity.

Stroke remains a leading cause of mortality and disability globally, underlining the significance of early detection and rapid monitoring in improving survival rates and quality of life.

“Stroke affects millions globally, leading to significant mortality and long-term disability. This funding enables us to scale our detection and monitoring solution, empowering physicians and their patients with an effective tool for point-of-care cerebrovascular monitoring.

Early intervention can significantly reduce the impact of stroke, shifting the focus from treatment to prevention,” said Alexander Ballatori, Co-Founder and CEO of StrokeDx.

“We believe in the potential of StrokeDx’s technology to change the diagnostic paradigm and ultimately improve outcomes for stroke patients. By providing accessible, advanced technology, we can reach millions of at-risk individuals, potentially saving countless lives and reducing the burden on healthcare systems around the world,” said, Managing Director of DigiTx Partners.

Source: businesswire.com

Report Abuse